After Tense Fights, An FDA Panel Said Pfizer Boosters Should Go To Older Adults And Others At High Risk
BuzzFeed - Latest 2021-09-17
Summary:
The advisory panel of outside health experts recommended that a third dose of the Pfizer vaccine be authorized for people over 65 and those at high risk, rejecting the benefit for the general population.
